What if we stopped trying to change the patient and changed the pill instead?
Lyndra Therapeutics was a clinical-stage biopharmaceutical company dedicated to developing long-acting oral therapies using its proprietary LYNX platform. Founded from technology developed at MIT, the platform enables a single pill to deliver medication over a week or longer, improving patient adherence across therapeutic areas including HIV, psychiatry, and contraception. The company ceased operations in March 2025 after raising over $380M.
Tech & App Stack is available on paid plans
Upgrade to Silver or higher to reveal the full technology and app stack for any company.
View pricingCreate a free account to see funding visualizations and detailed round data.
Create Free AccountDec 2023
Jun 2023
Jun 2020
Jan 2018
Jun 2015
Create a free account to see which investors have funded this company.
Create Free Account
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
South Korean biotech company and global leader in medical aesthetics, manufacturing botulinum tox...
Global full-service clinical research organization (CRO) and scientific advisory partner for biot...
Global clinical research organization specializing in early-stage clinical trials and bioanalytic...
Healthcare company applying technology to drug development by building nimble biotech subsidiarie...
Neuralink is building a brain-computer interface for medical needs and greater human potential.
